Frank Rimerman Advisors LLC Increases Position in Colgate-Palmolive Company $CL

Frank Rimerman Advisors LLC lifted its stake in Colgate-Palmolive Company (NYSE:CL) by 237.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 19,557 shares of the company’s stock after purchasing an additional 13,761 shares during the period. Frank Rimerman Advisors LLC’s holdings in Colgate-Palmolive were worth $1,545,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Copia Wealth Management purchased a new position in Colgate-Palmolive in the third quarter valued at about $29,000. Cloud Capital Management LLC purchased a new stake in shares of Colgate-Palmolive during the 3rd quarter worth approximately $30,000. Global Wealth Strategies & Associates boosted its stake in shares of Colgate-Palmolive by 300.0% during the 4th quarter. Global Wealth Strategies & Associates now owns 400 shares of the company’s stock worth $32,000 after acquiring an additional 300 shares in the last quarter. Grove Bank & Trust grew its holdings in shares of Colgate-Palmolive by 182.6% in the 4th quarter. Grove Bank & Trust now owns 407 shares of the company’s stock worth $32,000 after acquiring an additional 263 shares during the period. Finally, Kelleher Financial Advisors purchased a new position in Colgate-Palmolive in the 3rd quarter valued at approximately $35,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

CL stock opened at $85.43 on Thursday. The stock’s 50 day moving average price is $91.14 and its 200 day moving average price is $83.41. The firm has a market cap of $68.54 billion, a P/E ratio of 32.61, a PEG ratio of 3.92 and a beta of 0.34. The company has a debt-to-equity ratio of 18.82, a quick ratio of 0.54 and a current ratio of 0.83. Colgate-Palmolive Company has a 1 year low of $74.54 and a 1 year high of $99.33.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, January 30th. The company reported $0.95 earnings per share for the quarter, topping analysts’ consensus estimates of $0.91 by $0.04. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The company had revenue of $5.23 billion during the quarter, compared to analysts’ expectations of $5.13 billion. During the same period in the previous year, the firm posted $0.91 earnings per share. The business’s revenue for the quarter was up 5.8% compared to the same quarter last year. On average, sell-side analysts expect that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Monday, April 20th will be paid a $0.53 dividend. This represents a $2.12 annualized dividend and a yield of 2.5%. The ex-dividend date of this dividend is Monday, April 20th. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.52. Colgate-Palmolive’s dividend payout ratio is presently 79.39%.

Wall Street Analysts Forecast Growth

CL has been the subject of several research reports. UBS Group lifted their price objective on Colgate-Palmolive from $90.00 to $93.00 and gave the stock a “buy” rating in a report on Wednesday, January 14th. Rothschild & Co Redburn set a $93.00 price target on Colgate-Palmolive in a research report on Friday, February 13th. Morgan Stanley lifted their price target on Colgate-Palmolive from $87.00 to $100.00 and gave the stock an “overweight” rating in a research note on Monday, February 2nd. JPMorgan Chase & Co. boosted their price objective on shares of Colgate-Palmolive from $93.00 to $97.00 and gave the stock an “overweight” rating in a research report on Monday, February 2nd. Finally, Jefferies Financial Group increased their price objective on shares of Colgate-Palmolive from $85.00 to $91.00 and gave the company a “hold” rating in a research note on Monday, February 2nd. Eleven analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $95.19.

Insider Activity

In other news, CFO Stanley J. Sutula III sold 97,843 shares of the business’s stock in a transaction that occurred on Wednesday, February 4th. The shares were sold at an average price of $94.27, for a total value of $9,223,659.61. Following the completion of the transaction, the chief financial officer owned 55,310 shares of the company’s stock, valued at $5,214,073.70. The trade was a 63.89% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider John Hazlin sold 20,989 shares of the company’s stock in a transaction that occurred on Tuesday, February 10th. The shares were sold at an average price of $94.25, for a total transaction of $1,978,213.25. Following the transaction, the insider directly owned 17,645 shares in the company, valued at $1,663,041.25. The trade was a 54.33% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 184,683 shares of company stock worth $17,486,693. Company insiders own 0.34% of the company’s stock.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.